Small Dense Low-density Lipoprotein in Patients With Prediabetes and Type 2 Diabetes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-05-31

Study Completion Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is known that small dense LDL particles are associated with an increased cardiovascular risk. LDL particles can be separated by gradient gel electrophoresis (GGE) according to their size. The risk to suffer from coronary heart disease is 3-7 fold elevated in subjects with small dense LDL particles compared to subjects with large LDL particles. This study aims at evaluating the predictive value of small dense LDL particles in patients with prediabetes and type 2 diabetes mellitus concerning future changes in intima media thickness, flow-mediated dilation and other risk factors of atherosclerosis (e.g. insulin resistance). 60 patients with prediabetes or type 2 diabetes will be recruited for the study. Assessment will include medical history (risk factors), physical examination (blood pressure, BMI, waist-to-hip ratio), collection of serum, oral glucose tolerance test, measurement of intima media thickness and endothelial dysfunction by ultrasound. All measurements will be repeated after 2 years. Data will be analysed to assess whether the amount of small dense LDL particles can predict further structural and functional changes of the cardiovascular system or changes in the severity of the disease (insulin resistance).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Effect of Diabetes on the Incidence and the Extent of Coronary Artery Disease

NCT01585948

Patients Undergoing Coronary Angiography

COMPLETED

Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.

NCT03010956

Diabetes Mellitus

COMPLETED

Cardiovascular Risk Factors in Patients With Diabetes -a Prospective Study in Primary Care

NCT01049737

Diabetes Mellitus Type 2 Cardiovascular Diseases

COMPLETED

Progression of Coronary Atherosclerosis in Asymptomatic Diabetic Subjects

NCT02109835

Type 2 Diabetes Coronary Artery Disease

UNKNOWN

Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus

NCT00298844

Type 2 Diabetes Mellitus

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prediabetes / Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* impaired fasting glucose OR type 2 diabetes (ADA criteria)
* BMI \> 25 kg/m2
* given informed consent

Exclusion Criteria

* insulin therapy
* fasting glucose \> 11mmol/l
* total cholesterol \> 6.5 mmol/l OR triglycerides \> 2.5 mmol/l
* malignant or severe renal, hepatic, pulmonary, neurological or psychiatric disease
* alcohol or drug abuse
* HIV infection.

Minimum Eligible Age

20 Years

Maximum Eligible Age

90 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No